Virtual Medicinal Product (VMP)
-
Cefuroxime 250mg powder for solution for injection vials
Name Details
Current Name
Cefuroxime 250mg powder for solution for injection vials
|
Start Date
14-03-2022
|
End Date
|
Previous Name
Cefuroxime 250mg powder for injection vials
|
Start Date
19-07-2006
|
End Date
13-03-2022
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- vial
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intravenous, Intramuscular
- Form
- Powder for solution for injection
- Ontology Form/Route
- solutioninjection.intravenous, suspensioninjection.intramuscular, solutioninfusion.intravenous
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
J01DC02
BNF |
Current BNF
05010201
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
05010201
|
Start Date
06-03-2009
|
End Date
03-04-2022
|
Previous BNF
05010200
|
Start Date
01-02-2005
|
End Date
05-03-2009
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
41945911000001109 |
09-06-2023 |
|
323880005 |
29-07-2003 |
08-06-2023 |
VMP Ingredients
Name
Cefuroxime sodium
Basis of strength description
Based on Base Substance
BOSS
Cefuroxime
Strength and UOM (Nmr)
250
Strength and UOM (Dmr)
Parent Products
-
VTM
Cefuroxime
-
VMP
(Current) Cefuroxime 250mg powder for solution...
Virtual Medicinal Product Pack (VMPP) Information